Loading...
XASE
PHGE
Market cap4mUSD
Sep 10, Last price  
1.85USD
Name

Biomx Inc

Chart & performance

D1W1MN
XASE:PHGE chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
166.48%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
-36m
L+104.20%
-6,433,000-12,720,000-20,563,000-30,086,000-36,226,000-28,317,000-26,169,000-17,727,000-36,199,000
CFO
-26m
L-28.64%
-4,100,000-11,304,000-11,304,000-17,577,000-24,447,000-27,573,000-29,092,000-21,286,000-36,979,000-26,390,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating as a holding company, BiomX Inc. is dedicated to advancing technologies within the realms of defense, security, and essential infrastructure. Its diverse array of offerings features specialized solutions like counter-unmanned aerial vehicle systems, intelligent AI-powered command-and-control, comprehensive border and perimeter protection, expansive surveillance capabilities, and aerial fire suppression tools. The firm caters to a broad spectrum of clients, encompassing national defense organizations, primary government contractors, transportation management entities, local municipalities, and key infrastructure operators. BiomX Inc. commenced operations in 2015 and maintains its principal office in Dover, Delaware.

Key people

Independent Chairman of the Board · since 2019
Jonathan Solomon
Chief Executive Officer, Director · since 2019
Marina Wolfson
Chief Financial Officer · since 2022
Merav Bassan
Chief Development Officer · since 2019
Assaf Oron
Chief Business Officer · since 2022
Gregory Merril
Director · since 2024
Susan Blum
Independent Director · since 2024
Independent Director · since 2020
Eddie Williams
Independent Director · since 2023
Reuven Yeganeh
Independent Director · since 2026
IPO date
Dec 18, 2018
Employees
54
Domiciled in
IL
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122019‑062018‑122018‑062017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT